Robert Wasserman
Stock Analyst at Benchmark Co.
(4.03)
# 1,633
Out of 4,377 analysts
227
Total ratings
44.3%
Success rate
8.4%
Average return
Main Sectors:
Stocks Rated by Robert Wasserman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XOMA XOMA Royalty | Downgraded: Hold | n/a | $42.09 | - | 4 | May 22, 2026 | |
| ITGR Integer Holdings | Upgraded: Buy | $140 → $95 | $91.98 | +3.28% | 18 | Feb 20, 2026 | |
| HALO Halozyme Therapeutics | Maintained: Buy | $90 | $71.53 | +25.82% | 22 | Feb 19, 2026 | |
| TLV: KMDA Kamada Ltd. | Maintained: Buy | ILA 4,395 | $2,157.00 | +103.77% | 4 | Jan 8, 2026 | |
| LGND Ligand Pharmaceuticals | Maintained: Buy | $220 | $237.00 | -7.17% | 19 | Dec 10, 2025 | |
| CDXS Codexis | Maintained: Hold | n/a | $2.56 | - | 16 | Nov 14, 2025 | |
| OABI OmniAb | Maintained: Buy | $6 → $4 | $2.48 | +61.29% | 11 | Nov 6, 2025 | |
| PRLB Proto Labs | Maintained: Buy | $45 → $55 | $72.64 | -24.28% | 13 | Nov 3, 2025 | |
| INTS Intensity Therapeutics | Maintained: Buy | $38 | $3.77 | +894.69% | 7 | Oct 31, 2025 | |
| RGEN Repligen | Maintained: Hold | n/a | $122.31 | - | 10 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $5.62 | - | 8 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $3.38 | +47.93% | 8 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $26.65 | +12.57% | 10 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $8.07 | +48.70% | 20 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 | $51.99 | +44.26% | 17 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $1.68 | +78.57% | 8 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 | $3.90 | n/a | 1 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $472.80 | n/a | 7 | Oct 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $184.30 | n/a | 5 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $5.65 | n/a | 4 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $80 | $2.52 | n/a | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $2.65 | n/a | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.37 | n/a | 3 | Jan 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $0.869 | n/a | 1 | Jan 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4.2 | $1.67 | n/a | 1 | Oct 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $46 | $0.1672 | n/a | 1 | Aug 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $2.30 | n/a | 2 | Jan 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5.25 | $1.36 | n/a | 1 | Nov 7, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $3.23 | n/a | 1 | Mar 12, 2013 |
XOMA Royalty
May 22, 2026
Downgraded: Hold
Price Target: n/a
Current: $42.09
Upside: -
Integer Holdings
Feb 20, 2026
Upgraded: Buy
Price Target: $140 → $95
Current: $91.98
Upside: +3.28%
Halozyme Therapeutics
Feb 19, 2026
Maintained: Buy
Price Target: $90
Current: $71.53
Upside: +25.82%
Kamada Ltd.
Jan 8, 2026
Maintained: Buy
Price Target: ILA 4,395
Current: $2,157.00
Upside: +103.77%
Ligand Pharmaceuticals
Dec 10, 2025
Maintained: Buy
Price Target: $220
Current: $237.00
Upside: -7.17%
Codexis
Nov 14, 2025
Maintained: Hold
Price Target: n/a
Current: $2.56
Upside: -
OmniAb
Nov 6, 2025
Maintained: Buy
Price Target: $6 → $4
Current: $2.48
Upside: +61.29%
Proto Labs
Nov 3, 2025
Maintained: Buy
Price Target: $45 → $55
Current: $72.64
Upside: -24.28%
Intensity Therapeutics
Oct 31, 2025
Maintained: Buy
Price Target: $38
Current: $3.77
Upside: +894.69%
Repligen
Oct 29, 2025
Maintained: Hold
Price Target: n/a
Current: $122.31
Upside: -
Aug 13, 2025
Maintained: Hold
Price Target: n/a
Current: $5.62
Upside: -
Aug 12, 2025
Maintained: Buy
Price Target: $5
Current: $3.38
Upside: +47.93%
Aug 11, 2025
Maintained: Buy
Price Target: $30
Current: $26.65
Upside: +12.57%
Aug 8, 2025
Maintained: Buy
Price Target: $12
Current: $8.07
Upside: +48.70%
Aug 7, 2025
Maintained: Buy
Price Target: $75
Current: $51.99
Upside: +44.26%
Jul 31, 2025
Maintained: Buy
Price Target: $3
Current: $1.68
Upside: +78.57%
Feb 3, 2025
Downgraded: Hold
Price Target: $4
Current: $3.90
Upside: n/a
Oct 26, 2023
Maintained: Hold
Price Target: n/a
Current: $472.80
Upside: n/a
Oct 25, 2023
Maintained: Hold
Price Target: n/a
Current: $184.30
Upside: n/a
Sep 15, 2023
Maintained: Hold
Price Target: n/a
Current: $5.65
Upside: n/a
Apr 4, 2023
Maintained: Buy
Price Target: $9 → $80
Current: $2.52
Upside: n/a
Feb 24, 2021
Reiterated: Buy
Price Target: $9
Current: $2.65
Upside: n/a
Jan 24, 2020
Rated: Hold
Price Target: n/a
Current: $1.37
Upside: n/a
Jan 9, 2019
Initiated Coverage: Buy
Price Target: $11
Current: $0.869
Upside: n/a
Oct 17, 2018
Initiated Coverage: Buy
Price Target: $4.2
Current: $1.67
Upside: n/a
Aug 28, 2018
Initiated Coverage: Buy
Price Target: $46
Current: $0.1672
Upside: n/a
Jan 29, 2018
Initiated Coverage: Buy
Price Target: n/a
Current: $2.30
Upside: n/a
Nov 7, 2013
Initiated Coverage: Buy
Price Target: $5.25
Current: $1.36
Upside: n/a
Mar 12, 2013
Reiterated: Buy
Price Target: $6
Current: $3.23
Upside: n/a